NRG-CC010
Open to Accrual
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase III Trial of the Impact of Sentinel Lymph Node Mapping On Patient Reported Lower Extremity Limb Dysfunction in Endometrial Cancer
Principal Investigator
Co-Principal Investigator(s)
Status
Open to Accrual
Date Opened To Accrual
September 19, 2022
Disease Site
Gynecologic [GY] Uterine Corpus
Phase
III
Developmental Therapeutics
No
Primary Objective
To compare the rates of lower extremity limb dysfunction (defined as a ≥4-point increase in GCLQ symptom score from baseline) in patients with apparent uterine confined endometrial cancer randomized to one of two lymphatic assessment strategies at time of hysterectomy.
Patient Population
Stage I endometrial cancer
Target Accrual
428
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
